These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6313594)

  • 1. Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients.
    Prentice HG
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():153-9. PubMed ID: 6313594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies in the prophylaxis of herpes infections in severely immunocompromised patients using acyclovir.
    Prentice HG; Hann IM
    Schweiz Med Wochenschr Suppl; 1983; 14():26-9. PubMed ID: 6361988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.
    Hann IM; Prentice HG; Blacklock HA; Ross MG; Brigden D; Rosling AE; Burke C; Crawford DH; Brumfitt W; Hoffbrand AV
    Br Med J (Clin Res Ed); 1983 Aug; 287(6389):384-8. PubMed ID: 6307464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation.
    Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Mazeron MC; Perol Y
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():161-7. PubMed ID: 6313595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclovir prophylaxis in bone marrow transplant recipients.
    Lundgren G; Wilczek H; Lönnqvist B; Lindholm A; Wahren B; Ringdén O
    Scand J Infect Dis Suppl; 1985; 47():137-44. PubMed ID: 3006228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential intravenous and twice-daily oral acyclovir for extended prophylaxis of herpes simplex virus infection in marrow transplant patients.
    Shepp DH; Dandliker PS; Flournoy N; Meyers JD
    Transplantation; 1987 May; 43(5):654-8. PubMed ID: 3554658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir.
    Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Nebout T; Mazeron MC; Perol Y
    Lancet; 1983 Sep; 2(8352):706-8. PubMed ID: 6136841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation.
    Selby PJ; Powles RL; Easton D; Perren TJ; Stolle K; Jameson B; Fiddian AP; Tryhorn Y; Stern H
    Br J Cancer; 1989 Mar; 59(3):434-8. PubMed ID: 2539180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acyclovir prophylaxis of herpes-simplex-virus infections.
    Saral R; Burns WH; Laskin OL; Santos GW; Lietman PS
    N Engl J Med; 1981 Jul; 305(2):63-7. PubMed ID: 6264292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of acyclovir in the prevention of herpes infections after allogenic bone marrow grafts].
    Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Mazeron MC; Pérol Y
    Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):391-6. PubMed ID: 6091231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study.
    Boeckh M; Kim HW; Flowers ME; Meyers JD; Bowden RA
    Blood; 2006 Mar; 107(5):1800-5. PubMed ID: 16282339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.
    Meyers JD; Reed EC; Shepp DH; Thornquist M; Dandliker PS; Vicary CA; Flournoy N; Kirk LE; Kersey JH; Thomas ED
    N Engl J Med; 1988 Jan; 318(2):70-5. PubMed ID: 2827025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group.
    Prentice HG; Gluckman E; Powles RL; Ljungman P; Milpied N; Fernandez Rañada JM; Mandelli F; Kho P; Kennedy L; Bell AR
    Lancet; 1994 Mar; 343(8900):749-53. PubMed ID: 7907729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclovir and renal transplantation.
    Pettersson E; Eklund B; Höckerstedt K; Salmela K; Ahonen J
    Scand J Infect Dis Suppl; 1985; 47():145-8. PubMed ID: 3912970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantation.
    Shepp DH; Dandliker PS; Flournoy N; Meyers JD
    J Antimicrob Chemother; 1985 Sep; 16(3):389-95. PubMed ID: 2997101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
    Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
    Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients.
    Shepp DH; Newton BA; Dandliker PS; Flournoy N; Meyers JD
    Ann Intern Med; 1985 Jun; 102(6):783-5. PubMed ID: 2986508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
    Wagstaff AJ; Faulds D; Goa KL
    Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.